Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.82
Delayed Data
As of 12:13pm ET
 -0.06 / -2.08%
Today’s Change
1.81
Today|||52-Week Range
3.15
+36.23%
Year-to-Date

Today’s Trading

Previous close2.88
Today’s open2.87
Day’s range2.81 - 2.88
Volume248,706
Average volume (3 months)1,729,906
Market cap$458.4M
Dividend yield--
Data as of 12:13pm ET, 06/29/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book3.75

Competitors

 Today’s
change
Today’s
% change
SYRSSyros Pharmaceutical...-0.41-2.32%
BCRXBioCryst Pharmaceuti...-0.24-4.12%
ADAPAdaptimmune Therapeu...-0.15-3.14%
BLCMBellicum Pharmaceuti...-1.37-10.29%
Data as of 12:29pm ET, 06/29/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts